Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell lysis via herpes simplex virus type 1 replication
- Molecular classification
- Viral replication, Oncolytic virus
01
Overview
Tumor cell lysis via herpes simplex virus type 1 replication exploits the ability of engineered or wild-type HSV-1 viruses to selectively infect and destroy cancerous tissues by hijacking cellular processes for robust viral propagation. This approach forms the foundation for modern oncolytic virotherapies such as T-VEC that combine direct cytolytic effects with stimulation of systemic anti-tumoral immunity.
02
Mechanism of action
Selective replication within tumor cells leading to cell lysis and release of tumor antigens, stimulating anti-tumor immune responses.
03
Biological functions
Cell lysisViral replicationAnti-tumor immunityTumor cell death
04
Disease associations
Cancer
05
Safety considerations
Potential for off-target infectionImmune-related adverse eventsRisk of viral shedding
06
Interacting drugs
Talimogene laherparepvec (T-VEC)
Beyond the preview
Go deeper on Tumor cell lysis via herpes simplex virus type 1 replication.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor cell lysis via herpes simplex virus type 1 replication.